![O3Y O3Y](https://data.pdbj.org/pdbjplus/data/cc/svg/O3Y.svg) | O3Y | Name: | 4-(2-chlorophenyl)-3-hydroxy-7,7-dimethyl-2-phenyl-2,6,7,8-tetrahydro-5H-pyrazolo[3,4-b]quinolin-5-one | Formula: | C24 H20 Cl N3 O2 | SMILES: | c24nc1CC(C)(C)CC(c1c(c2c(n(c3ccccc3)n4)O)c5c(Cl)cccc5)=O | InChi: | InChI=1S/C24H20ClN3O2/c1-24(2)12-17-20(18(29)13-24)19(15-10-6-7-11-16(15)25)21-22(26-17)27-28(23(21)30)14-8-4-3-5-9-14/h3-11,30H,12-13H2,1-2H3 | Definition date: | 2019-06-07 | Last modified: | 2019-08-23 | Release date: | 2019-08-28 | Identifier: | 4-(2-chlorophenyl)-3-hydroxy-7,7-dimethyl-2-phenyl-2,6,7,8-tetrahydro-5H-pyrazolo[3,4-b]quinolin-5-one |
|
![O4D O4D](https://data.pdbj.org/pdbjplus/data/cc/svg/O4D.svg) | O4D | Name: | 2-[4,6-dimethyl-3-(1H-pyrrol-1-yl)-1H-pyrazolo[3,4-b]pyridin-1-yl]-N-[3-(morpholin-4-yl)propyl]acetamide | Formula: | C21 H28 N6 O2 | SMILES: | c2(c3c(n(CC(NCCCN1CCOCC1)=O)n2)nc(cc3C)C)n4cccc4 | InChi: | InChI=1S/C21H28N6O2/c1-16-14-17(2)23-20-19(16)21(26-8-3-4-9-26)24-27(20)15-18(28)22-6-5-7-25-10-12-29-13-11-25/h3-4,8-9,14H,5-7,10-13,15H2,1-2H3,(H,22,28) | Definition date: | 2019-06-07 | Last modified: | 2019-08-23 | Release date: | 2019-08-28 | Identifier: | 2-[4,6-dimethyl-3-(1H-pyrrol-1-yl)-1H-pyrazolo[3,4-b]pyridin-1-yl]-N-[3-(morpholin-4-yl)propyl]acetamide |
|
![O4S O4S](https://data.pdbj.org/pdbjplus/data/cc/svg/O4S.svg) | O4S | Name: | N-[(4-ethylphenyl)methyl]-2-[(6aR)-6-oxo-3-(pyrrolidine-1-carbonyl)-6,6a,7,8,9,10-hexahydro-5H-pyrido[1,2-a]quinoxalin-5-yl]acetamide | Formula: | C28 H34 N4 O3 | SMILES: | C2(N(c1cc(ccc1N3CCCCC23)C(N4CCCC4)=O)CC(NCc5ccc(CC)cc5)=O)=O | InChi: | InChI=1S/C28H34N4O3/c1-2-20-8-10-21(11-9-20)18-29-26(33)19-32-25-17-22(27(34)30-14-5-6-15-30)12-13-23(25)31-16-4-3-7-24(31)28(32)35/h8-13,17,24H,2-7,14-16,18-19H2,1H3,(H,29,33)/t24-/m1/s1 | Definition date: | 2019-06-07 | Last modified: | 2019-08-23 | Release date: | 2019-08-28 | Identifier: | N-[(4-ethylphenyl)methyl]-2-[(6aR)-6-oxo-3-(pyrrolidine-1-carbonyl)-6,6a,7,8,9,10-hexahydro-5H-pyrido[1,2-a]quinoxalin-5-yl]acetamide |
|
![O5S O5S](https://data.pdbj.org/pdbjplus/data/cc/svg/O5S.svg) | O5S | Name: | 2-[5-chloro-2-cyclopropyl-3-(5-methoxy-3,4-dihydroisoquinoline-2(1H)-carbonyl)-7-methyl-1H-indol-1-yl]-N-(1-propanoylazetidin-3-yl)acetamide | Formula: | C31 H35 Cl N4 O4 | SMILES: | CCC(N6CC(NC(=O)Cn1c5c(c(c1C2CC2)C(N4CCc3c(OC)cccc3C4)=O)cc(Cl)cc5C)C6)=O | InChi: | InChI=1S/C31H35ClN4O4/c1-4-27(38)35-15-22(16-35)33-26(37)17-36-29-18(2)12-21(32)13-24(29)28(30(36)19-8-9-19)31(39)34-11-10-23-20(14-34)6-5-7-25(23)40-3/h5-7,12-13,19,22H,4,8-11,14-17H2,1-3H3,(H,33,37) | Definition date: | 2019-06-12 | Last modified: | 2019-08-23 | Release date: | 2019-08-28 | Identifier: | 2-[5-chloro-2-cyclopropyl-3-(5-methoxy-3,4-dihydroisoquinoline-2(1H)-carbonyl)-7-methyl-1H-indol-1-yl]-N-(1-propanoylazetidin-3-yl)acetamide |
|
![O5Y O5Y](https://data.pdbj.org/pdbjplus/data/cc/svg/O5Y.svg) | O5Y | Name: | 2-[5-bromo-3-(5-methoxy-3,4-dihydroisoquinoline-2(1H)-carbonyl)-1H-indol-1-yl]-N-(1-propanoylazetidin-3-yl)acetamide | Formula: | C27 H29 Br N4 O4 | SMILES: | CCC(N5CC(NC(=O)Cn3cc(C(=O)N1Cc2c(CC1)c(ccc2)OC)c4cc(Br)ccc34)C5)=O | InChi: | InChI=1S/C27H29BrN4O4/c1-3-26(34)32-13-19(14-32)29-25(33)16-31-15-22(21-11-18(28)7-8-23(21)31)27(35)30-10-9-20-17(12-30)5-4-6-24(20)36-2/h4-8,11,15,19H,3,9-10,12-14,16H2,1-2H3,(H,29,33) | Definition date: | 2019-06-12 | Last modified: | 2019-08-23 | Release date: | 2019-08-28 | Identifier: | 2-[5-bromo-3-(5-methoxy-3,4-dihydroisoquinoline-2(1H)-carbonyl)-1H-indol-1-yl]-N-(1-propanoylazetidin-3-yl)acetamide |
|
![J7S J7S](https://data.pdbj.org/pdbjplus/data/cc/svg/J7S.svg) | J7S | Name: | 4-(2-chloropyrido[2,3-d]pyrimidin-4-yl)-7-methoxy-3,4-dihydroquinoxalin-2(1H)-one | Formula: | C16 H12 Cl N5 O2 | SMILES: | O=C1CN(c2c(N1)cc(OC)cc2)c4c3c(nccc3)nc(n4)Cl | InChi: | InChI=1S/C16H12ClN5O2/c1-24-9-4-5-12-11(7-9)19-13(23)8-22(12)15-10-3-2-6-18-14(10)20-16(17)21-15/h2-7H,8H2,1H3,(H,19,23) | Definition date: | 2018-08-20 | Last modified: | 2019-08-16 | Release date: | 2019-08-21 | Identifier: | 4-(2-chloropyrido[2,3-d]pyrimidin-4-yl)-7-methoxy-3,4-dihydroquinoxalin-2(1H)-one |
|
![O1D O1D](https://data.pdbj.org/pdbjplus/data/cc/svg/O1D.svg) | O1D | Name: | 3-(benzyloxy)aniline | Formula: | C13 H13 N O | SMILES: | c2(OCc1ccccc1)cc(N)ccc2 | InChi: | InChI=1S/C13H13NO/c14-12-7-4-8-13(9-12)15-10-11-5-2-1-3-6-11/h1-9H,10,14H2 | Definition date: | 2019-06-04 | Last modified: | 2019-08-16 | Release date: | 2019-08-21 | Identifier: | 3-(benzyloxy)aniline |
|
![O2J O2J](https://data.pdbj.org/pdbjplus/data/cc/svg/O2J.svg) | O2J | Name: | (2R)-2-(methoxymethyl)-4-(pyridin-2-yl)morpholine | Formula: | C11 H16 N2 O2 | SMILES: | N2(c1ccccn1)CCOC(C2)COC | InChi: | InChI=1S/C11H16N2O2/c1-14-9-10-8-13(6-7-15-10)11-4-2-3-5-12-11/h2-5,10H,6-9H2,1H3/t10-/m1/s1 | Definition date: | 2019-06-05 | Last modified: | 2019-08-16 | Release date: | 2019-08-21 | Identifier: | (2R)-2-(methoxymethyl)-4-(pyridin-2-yl)morpholine |
|
![O3M O3M](https://data.pdbj.org/pdbjplus/data/cc/svg/O3M.svg) | O3M | Name: | 4-[(3,4-dihydroisoquinolin-2(1H)-yl)methyl]phenol | Formula: | C16 H17 N O | SMILES: | C(N1CCc2c(C1)cccc2)c3ccc(cc3)O | InChi: | InChI=1S/C16H17NO/c18-16-7-5-13(6-8-16)11-17-10-9-14-3-1-2-4-15(14)12-17/h1-8,18H,9-12H2 | Definition date: | 2019-06-06 | Last modified: | 2019-08-16 | Release date: | 2019-08-21 | Identifier: | 4-[(3,4-dihydroisoquinolin-2(1H)-yl)methyl]phenol |
|
![SYT SYT](https://data.pdbj.org/pdbjplus/data/cc/svg/SYT.svg) | SYT | Name: | (5S,12bS)-5-methyl-6,7,12b,13-tetrahydro-2H,4H,10H-[1,3]dioxolo[4,5-g][1,3]dioxolo[7,8]isoquinolino[3,2-a]isoquinolin-5-ium | Formula: | C20 H20 N O4 | SMILES: | C[N+]34Cc2c1c(OCO1)ccc2CC3c5c(CC4)cc6c(c5)OCO6 | InChi: | InChI=1S/C20H20NO4/c1-21-5-4-13-7-18-19(24-10-23-18)8-14(13)16(21)6-12-2-3-17-20(15(12)9-21)25-11-22-17/h2-3,7-8,16H,4-6,9-11H2,1H3/q+1/t16-,21-/m0/s1 | Definition date: | 2019-05-29 | Last modified: | 2019-08-09 | Release date: | 2019-08-14 | Identifier: | (5S,12bS)-5-methyl-6,7,12b,13-tetrahydro-2H,4H,10H-[1,3]dioxolo[4,5-g][1,3]dioxolo[7,8]isoquinolino[3,2-a]isoquinolin-5-ium |
|
![A8U A8U](https://data.pdbj.org/pdbjplus/data/cc/svg/A8U.svg) | A8U | Name: | propyl (2~{R})-4-[2-[4-(1-azanylcyclopropyl)phenyl]quinolin-7-yl]carbonyl-2-methyl-piperazine-1-carboxylate | Formula: | C28 H32 N4 O3 | SMILES: | CCCOC(=O)N1CCN(C[CH]1C)C(=O)c2ccc3ccc(nc3c2)c4ccc(cc4)C5(N)CC5 | InChi: | InChI=1S/C28H32N4O3/c1-3-16-35-27(34)32-15-14-31(18-19(32)2)26(33)22-5-4-21-8-11-24(30-25(21)17-22)20-6-9-23(10-7-20)28(29)12-13-28/h4-11,17,19H,3,12-16,18,29H2,1-2H3/t19-/m1/s1 | Definition date: | 2018-10-20 | Last modified: | 2019-08-09 | Release date: | 2019-08-14 | Identifier: | propyl (2~{R})-4-[2-[4-(1-azanylcyclopropyl)phenyl]quinolin-7-yl]carbonyl-2-methyl-piperazine-1-carboxylate |
|
![D6X D6X](https://data.pdbj.org/pdbjplus/data/cc/svg/D6X.svg) | D6X | Name: | N-[2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)ethyl]quinolin-2-amine | Formula: | C18 H18 N6 | SMILES: | Cc1cc(C)n2nc(CCNc3ccc4ccccc4n3)nc2n1 | InChi: | InChI=1S/C18H18N6/c1-12-11-13(2)24-18(20-12)22-17(23-24)9-10-19-16-8-7-14-5-3-4-6-15(14)21-16/h3-8,11H,9-10H2,1-2H3,(H,19,21) | Definition date: | 2019-07-12 | Last modified: | 2019-08-09 | Release date: | 2019-08-14 | Identifier: | ~{N}-[2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)ethyl]quinolin-2-amine |
|
![JKN JKN](https://data.pdbj.org/pdbjplus/data/cc/svg/JKN.svg) | JKN | Name: | 6,8-bis(fluoranyl)-2-[4-(2-oxidanylpropan-2-yl)phenyl]-3~{H}-quinazolin-4-one | Formula: | C17 H14 F2 N2 O2 | SMILES: | CC(C)(O)c1ccc(cc1)C2=Nc3c(F)cc(F)cc3C(=O)N2 | InChi: | InChI=1S/C17H14F2N2O2/c1-17(2,23)10-5-3-9(4-6-10)15-20-14-12(16(22)21-15)7-11(18)8-13(14)19/h3-8,23H,1-2H3,(H,20,21,22) | Definition date: | 2019-03-08 | Last modified: | 2019-08-09 | Release date: | 2019-08-14 | Identifier: | 6,8-bis(fluoranyl)-2-[4-(2-oxidanylpropan-2-yl)phenyl]-3~{H}-quinazolin-4-one |
|
![B9O B9O](https://data.pdbj.org/pdbjplus/data/cc/svg/B9O.svg) | B9O | Name: | N-[(2S)-1-(1-benzothiophen-3-yl)-3-hydroxypropan-2-yl]-N~2~-methyl-L-valinamide | Formula: | C17 H24 N2 O2 S | SMILES: | N(C(C(=O)NC(Cc2c1ccccc1sc2)CO)C(C)C)C | InChi: | InChI=1S/C17H24N2O2S/c1-11(2)16(18-3)17(21)19-13(9-20)8-12-10-22-15-7-5-4-6-14(12)15/h4-7,10-11,13,16,18,20H,8-9H2,1-3H3,(H,19,21)/t13-,16-/m0/s1 | Definition date: | 2019-01-29 | Last modified: | 2019-08-02 | Release date: | 2019-08-07 | Identifier: | N-[(2S)-1-(1-benzothiophen-3-yl)-3-hydroxypropan-2-yl]-N~2~-methyl-L-valinamide |
|
![B9R B9R](https://data.pdbj.org/pdbjplus/data/cc/svg/B9R.svg) | B9R | Name: | N-[(2S)-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl]-N~2~-methyl-L-valinamide | Formula: | C17 H25 N3 O2 | SMILES: | N(C)C(C(NC(Cc2c1c(cccc1)nc2)CO)=O)C(C)C | InChi: | InChI=1S/C17H25N3O2/c1-11(2)16(18-3)17(22)20-13(10-21)8-12-9-19-15-7-5-4-6-14(12)15/h4-7,9,11,13,16,18-19,21H,8,10H2,1-3H3,(H,20,22)/t13-,16-/m0/s1 | Definition date: | 2019-01-29 | Last modified: | 2019-08-02 | Release date: | 2019-08-07 | Identifier: | N-[(2S)-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl]-N~2~-methyl-L-valinamide |
|
![K5N K5N](https://data.pdbj.org/pdbjplus/data/cc/svg/K5N.svg) | K5N | Name: | 2-methyl-~{N}-[(1~{R})-1-[4-(methylsulfonylcarbamoyl)phenyl]ethyl]-5-phenyl-pyrazole-3-carboxamide | Formula: | C21 H22 N4 O4 S | SMILES: | C[CH](NC(=O)c1cc(nn1C)c2ccccc2)c3ccc(cc3)C(=O)N[S](C)(=O)=O | InChi: | InChI=1S/C21H22N4O4S/c1-14(15-9-11-17(12-10-15)20(26)24-30(3,28)29)22-21(27)19-13-18(23-25(19)2)16-7-5-4-6-8-16/h4-14H,1-3H3,(H,22,27)(H,24,26)/t14-/m1/s1 | Definition date: | 2019-04-26 | Last modified: | 2019-08-02 | Release date: | 2019-08-07 | Identifier: | 2-methyl-~{N}-[(1~{R})-1-[4-(methylsulfonylcarbamoyl)phenyl]ethyl]-5-phenyl-pyrazole-3-carboxamide |
|
![NSJ NSJ](https://data.pdbj.org/pdbjplus/data/cc/svg/NSJ.svg) | NSJ | Name: | 3-[(thiomorpholin-4-yl)methyl]phenol | Formula: | C11 H15 N O S | SMILES: | N1(CCSCC1)Cc2cccc(c2)O | InChi: | InChI=1S/C11H15NOS/c13-11-3-1-2-10(8-11)9-12-4-6-14-7-5-12/h1-3,8,13H,4-7,9H2 | Definition date: | 2019-05-28 | Last modified: | 2019-08-02 | Release date: | 2019-08-07 | Identifier: | 3-[(thiomorpholin-4-yl)methyl]phenol |
|
![NT7 NT7](https://data.pdbj.org/pdbjplus/data/cc/svg/NT7.svg) | NT7 | Name: | N-(2,3-dimethylphenyl)-2-(morpholin-4-yl)acetamide | Formula: | C14 H20 N2 O2 | SMILES: | N(C(=O)CN1CCOCC1)c2cccc(c2C)C | InChi: | InChI=1S/C14H20N2O2/c1-11-4-3-5-13(12(11)2)15-14(17)10-16-6-8-18-9-7-16/h3-5H,6-10H2,1-2H3,(H,15,17) | Definition date: | 2019-05-28 | Last modified: | 2019-08-02 | Release date: | 2019-08-07 | Identifier: | N-(2,3-dimethylphenyl)-2-(morpholin-4-yl)acetamide |
|
![NW4 NW4](https://data.pdbj.org/pdbjplus/data/cc/svg/NW4.svg) | NW4 | Name: | 3-cyclohexyl-1-(morpholin-4-yl)propan-1-one | Formula: | C13 H23 N O2 | SMILES: | N1(CCOCC1)C(=O)CCC2CCCCC2 | InChi: | InChI=1S/C13H23NO2/c15-13(14-8-10-16-11-9-14)7-6-12-4-2-1-3-5-12/h12H,1-11H2 | Definition date: | 2019-05-28 | Last modified: | 2019-08-02 | Release date: | 2019-08-07 | Identifier: | 3-cyclohexyl-1-(morpholin-4-yl)propan-1-one |
|
![OXV OXV](https://data.pdbj.org/pdbjplus/data/cc/svg/OXV.svg) | OXV | Name: | ~{N}-[2-[2-[2-[2-[2-[2-[(1-methylquinolin-4-yl)methyl]-1,3-benzothiazol-3-yl]ethanoylamino]ethoxy]ethoxy]ethoxy]ethyl]pentanamide | Formula: | C33 H44 N4 O5 S | SMILES: | CCCCC(=O)NCCOCCOCCOCCNC(=O)C[n]1c(Cc2cc[n](C)c3ccccc23)sc4ccccc14 | InChi: | InChI=1S/C33H44N4O5S/c1-3-4-13-31(38)34-15-18-40-20-22-42-23-21-41-19-16-35-32(39)25-37-29-11-7-8-12-30(29)43-33(37)24-26-14-17-36(2)28-10-6-5-9-27(26)28/h5-12,14,17H,3-4,13,15-16,18-25H2,1-2H3,(H,34,38)(H,35,39) | Definition date: | 2019-07-15 | Last modified: | 2019-07-26 | Release date: | 2019-07-31 | Identifier: | ~{N}-[2-[2-[2-[2-[2-[2-[(1-methylquinolin-4-yl)methyl]-1,3-benzothiazol-3-yl]ethanoylamino]ethoxy]ethoxy]ethoxy]ethyl]pentanamide |
|
![JJN JJN](https://data.pdbj.org/pdbjplus/data/cc/svg/JJN.svg) | JJN | Name: | (6~{a}~{R},11~{b}~{S})-6~{a}-(1,4-dimethylpiperidin-4-yl)-7,11~{b}-dihydro-6~{H}-indolo[2,3-c]isoquinolin-5-one | Formula: | C22 H25 N3 O | SMILES: | CN1CCC(C)(CC1)[C]23NC(=O)c4ccccc4[CH]2c5ccccc5N3 | InChi: | InChI=1S/C22H25N3O/c1-21(11-13-25(2)14-12-21)22-19(17-9-5-6-10-18(17)23-22)15-7-3-4-8-16(15)20(26)24-22/h3-10,19,23H,11-14H2,1-2H3,(H,24,26)/t19-,22+/m0/s1 | Definition date: | 2019-02-28 | Last modified: | 2019-07-26 | Release date: | 2019-07-31 | Identifier: | (6~{a}~{R},11~{b}~{S})-6~{a}-(1,4-dimethylpiperidin-4-yl)-7,11~{b}-dihydro-6~{H}-indolo[2,3-c]isoquinolin-5-one |
|
![XX0 XX0](https://data.pdbj.org/pdbjplus/data/cc/svg/XX0.svg) | XX0 | Name: | 2-chloro-N-{4-chloro-3-[(morpholin-4-yl)sulfonyl]phenyl}acetamide | Formula: | C12 H14 Cl2 N2 O4 S | SMILES: | C(C(=O)Nc1ccc(Cl)c(c1)S(=O)(=O)N2CCOCC2)Cl | InChi: | InChI=1S/C12H14Cl2N2O4S/c13-8-12(17)15-9-1-2-10(14)11(7-9)21(18,19)16-3-5-20-6-4-16/h1-2,7H,3-6,8H2,(H,15,17) | Definition date: | 2019-07-03 | Last modified: | 2019-07-19 | Release date: | 2019-07-24 | Identifier: | 2-chloro-N-{4-chloro-3-[(morpholin-4-yl)sulfonyl]phenyl}acetamide |
|
![G8E G8E](https://data.pdbj.org/pdbjplus/data/cc/svg/G8E.svg) | G8E | Name: | 3-azanyl-6-(4-morpholin-4-ylsulfonylphenyl)-~{N}-pyridin-3-yl-pyrazine-2-carboxamide | Formula: | C20 H20 N6 O4 S | SMILES: | Nc1ncc(nc1C(=O)Nc2cccnc2)c3ccc(cc3)[S](=O)(=O)N4CCOCC4 | InChi: | InChI=1S/C20H20N6O4S/c21-19-18(20(27)24-15-2-1-7-22-12-15)25-17(13-23-19)14-3-5-16(6-4-14)31(28,29)26-8-10-30-11-9-26/h1-7,12-13H,8-11H2,(H2,21,23)(H,24,27) | Definition date: | 2018-09-05 | Last modified: | 2019-07-12 | Release date: | 2019-07-17 | Identifier: | 3-azanyl-6-(4-morpholin-4-ylsulfonylphenyl)-~{N}-pyridin-3-yl-pyrazine-2-carboxamide |
|
![D4L D4L](https://data.pdbj.org/pdbjplus/data/cc/svg/D4L.svg) | D4L | Name: | 2-(3,7-dimethylquinoxalin-2-yl)-~{N}-(oxan-4-yl)-5-pyrrolidin-1-yl-pyrazolo[1,5-a]pyrimidin-7-amine | Formula: | C25 H29 N7 O | SMILES: | Cc1ccc2nc(C)c(nc2c1)c3cc4nc(cc(NC5CCOCC5)n4n3)N6CCCC6 | InChi: | InChI=1S/C25H29N7O/c1-16-5-6-19-20(13-16)28-25(17(2)26-19)21-14-23-29-22(31-9-3-4-10-31)15-24(32(23)30-21)27-18-7-11-33-12-8-18/h5-6,13-15,18,27H,3-4,7-12H2,1-2H3 | Definition date: | 2019-06-25 | Last modified: | 2019-07-12 | Release date: | 2019-07-17 | Identifier: | 2-(3,7-dimethylquinoxalin-2-yl)-~{N}-(oxan-4-yl)-5-pyrrolidin-1-yl-pyrazolo[1,5-a]pyrimidin-7-amine |
|
![K9T K9T](https://data.pdbj.org/pdbjplus/data/cc/svg/K9T.svg) | K9T | Name: | 2-[4-(1,3-benzothiazol-5-ylamino)-6-~{tert}-butylsulfonyl-quinazolin-7-yl]oxyethyl dihydrogen phosphate | Formula: | C21 H23 N4 O7 P S2 | SMILES: | CC(C)(C)[S](=O)(=O)c1cc2c(Nc3ccc4scnc4c3)ncnc2cc1OCCO[P](O)(O)=O | InChi: | InChI=1S/C21H23N4O7PS2/c1-21(2,3)35(29,30)19-9-14-15(10-17(19)31-6-7-32-33(26,27)28)22-11-23-20(14)25-13-4-5-18-16(8-13)24-12-34-18/h4-5,8-12H,6-7H2,1-3H3,(H,22,23,25)(H2,26,27,28) | Definition date: | 2019-05-08 | Last modified: | 2019-07-12 | Release date: | 2019-07-17 | Identifier: | 2-[4-(1,3-benzothiazol-5-ylamino)-6-~{tert}-butylsulfonyl-quinazolin-7-yl]oxyethyl dihydrogen phosphate |
|